HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-((Pyrrolidine-1-carbonyl)methyl)piperazine → HCID 17754725, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-((Pyrrolidine-1-carbonyl)methyl)piperazine | HCID 100614 | — |
| Reactant | rac-(4S*,5R*)-4,5-bis-(4-chloro-phenyl)-2-[2-ethoxy-4-(1-hydroxy-1-methyl-ethyl)-phenyl]-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride | HCID 73408763 | — |
| Product | HCID 17754725 | HCID 17754725 | — |
Reaction Steps
In a manner analogous to the method described in example 5, rac-(4S*,5R*)-4,5-bis-(4-chloro-phenyl)-2-[2-ethoxy-4-(1-hydroxy-1-methyl-ethyl)-phenyl]-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride was reacted with 2-piperazin-1-yl-1-pyrrolidin-1-yl-ethanone (Aldrich) to give the title compound as a racemic mixture. The enantiomers were then separated by supercritical fluid chromatography (Berger Instrument Multi-Gram II, Daicel ChiralPak OD-H 3×25 cm, 35° C. at 100 bar, eluting with 25% methanol in carbon dioxide). HR-MS (ES, m/z) calculated for C39H48N5O4Cl2 [(M+H)+] 720.3078, observed 720.3072.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07851626B2 |
| Source dataset | uspto-grants-2010_12 |
| ORD ID | ord-e72f17d03bc6449dbc86b5c90b3109d0 |
| Source note | uspto-grants-2010_12 |